7JZM
SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3)
Summary for 7JZM
Entry DOI | 10.2210/pdb7jzm/pdb |
EMDB information | 22533 |
Descriptor | LCB3, Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total) |
Functional Keywords | sars-cov-2, covid-19, spike glycoprotein, fusion protein, neutralizing antibodies, structural genomics, seattle structural genomics center for infectious disease, ssgcid, inhibitor, viral protein |
Biological source | synthetic construct More |
Total number of polymer chains | 2 |
Total formula weight | 154943.26 |
Authors | Park, Y.J.,Veesler, D.,Seattle Structural Genomics Center for Infectious Disease (SSGCID) (deposition date: 2020-09-02, release date: 2020-09-23, Last modification date: 2020-11-04) |
Primary citation | Cao, L.,Goreshnik, I.,Coventry, B.,Case, J.B.,Miller, L.,Kozodoy, L.,Chen, R.E.,Carter, L.,Walls, A.C.,Park, Y.J.,Strauch, E.M.,Stewart, L.,Diamond, M.S.,Veesler, D.,Baker, D. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science, 370:426-431, 2020 Cited by PubMed: 32907861DOI: 10.1126/science.abd9909 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3.5 Å) |
Structure validation
Download full validation report